Guru Ownership Trend
Guru Analysis for Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $72.26 M.
Top institutional holders include George Soros and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $16.22 M net inflow during the quarter.
Recent activity highlights George Soros who opened a new position. Conversely, Steven Cohen reduced exposure by 79.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Day One Biopharmaceuticals, Inc. (DAWN)
Major holders include George Soros ($33 M), Renaissance Technologies (RenTech) ($27.81 M), Cliff Asness ($9.53 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.36 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $16.22 M, with 2 managers increasing positions and 5 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited DAWN. The total reported sell value was $17.05 M.
Yes, 1 managers opened new positions in DAWN, and 1 increased their existing holdings. The total reported buy value was $33.27 M.